Investigation of the effects of slow release carbohydrate digestion on satiety and related blood biomarkers of satiety and energy release

ISRCTN ISRCTN46403895
DOI https://doi.org/10.1186/ISRCTN46403895
Protocol serial number REC/10/0013
Sponsor University of Ulster (UK)
Funder Nestle (UK)
Submission date
28/09/2010
Registration date
25/11/2010
Last edited
12/12/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Julie Wallace
Scientific

Northern Ireland Centre for Food and Health
University of Ulster
Coleraine
BT52 1SA
United Kingdom

Study information

Primary study designInterventional
Study designRandomised double blind crossover group trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleInvestigation of the effects of slow release carbohydrate digestion on satiety and related blood biomarkers of satiety and energy release: A randomised, double blinded, crossover trial
Study objectivesConsumption of slow carbohydrate digestion will influence satiety, related blood biomarkers of satiety and energy release, and subsequent food intake
Ethics approval(s)The University of Ulster Research Ethics Committee approved on the 23rd of May 2010 (REC/10/0013)
Health condition(s) or problem(s) studiedFood metabolism
InterventionEach patient will undergo each of the following conditions on the same day of each week and with a minimum one week interval between study conditions:
1. Control (rapidly digestible starches)
2. 10g slow digestible starch
3. 25g slow digestible starch
The order in which the patient undergoes these conditions will be randomised.
Intervention typeOther
Primary outcome measure(s)

Food and nutrient intake:
1. Energy intake (kJ)
2. Macronutrient intakes (g and % energy)
3. Weight of food and beverages (g) consumed
Assessed following a test meal served 4 hours after consuming each of the test products.

Key secondary outcome measure(s)

1. Subjective satiety ratings:
Visual analogue scales (VAS) to assess feelings of hunger, fullness, thirst, preoccupation with thoughts of food and desire to eat will be made on each study condition
2. Hormonal and metabolic responses:
Blood samples will be taken at each study condition by venous cannula and analysed for the following metabolites:
2.1. Glucose
2.2. Insulin
2.3. Glucagon-Like Peptide (GLP-1)
2.4. Ghrelin
2.5. Peptide YY (PYY)
(GLP-1, Ghrelin, and PYY only being analysed if there is a positive outcome for the outer measures)

Completion date31/01/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration38
Key inclusion criteria1. Aged between 19-55 years
2. Body Mass Index (BMI) > 20 and < 25
3. In good health condition (no cardiovascular, respiratory, neurological or metabolic disease such as diabetes)
4. Willing to consume the test products
Key exclusion criteria1. Regular use of medication (apart from OTC medication)
2. Smoking
Date of first enrolment01/06/2010
Date of final enrolment31/01/2011

Locations

Countries of recruitment

  • United Kingdom
  • Northern Ireland

Study participating centre

Northern Ireland Centre for Food and Health
Coleraine
BT52 1SA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes